All posts by imreal

Constructing a Pharma Development & Manufacturing Project Plan:…


In this free webinar, learn about constructing a pharma development and manufacturing project plan with steps to evaluate risk and find efficiencies. Attendees will learn about the major decision…

(PRWeb November 10, 2022)

Read the full story at https://www.prweb.com/releases/constructing_a_pharma_development_manufacturing_project_plan_steps_to_evaluate_risk_find_efficiencies_upcoming_webinar_hosted_by_xtalks/prweb19011427.htm

Scaling DCTs to Drive the Transformation of Clinical Development, Upcoming Webinar Hosted by Xtalks


Now that many sponsors are embracing DCT strategies, these organizations will need to focus on scaling their approach in implementing digital capabilities to ensure long-term success and achieving a positive ROI.

It’s no secret that the COVID-19 pandemic drove a rapid increase in the adoption of decentralized clinical trials (DCTs) across the life sciences industry. Utilizing digital technologies has demonstrated ample benefits to sponsors, study teams and importantly, patients. These benefits include increasing efficiency across clinical operations and data management, simplifying the sponsor technology ecosystem, reducing patient and site burden, accelerating timelines, providing access to real-time data and insights, improving access to more diverse patient populations and more.

Now that many sponsors are embracing DCT strategies, these organizations will need to focus on scaling their approach in implementing digital capabilities to ensure long-term success and achieving a positive ROI. To achieve scale, digital strategies need to be embedded early into the pipeline of pharma and biotech companies, requiring the creation of standardized processes and an ecosystem of partners who work together to achieve a common goal.

Register for this webinar where a panel of industry experts from Medable, Syneos and Veeva will provide best practices and examples on how to successfully implement and scale patient-first DCTs across an organization to drive transformation of the clinical development process while mitigating potential risks.

Join Sam Bavery, Senior Director, Strategy & Growth, Medable; Juliet Hulse, Executive Director, Global RN Strategy and Patient Advocacy, Illingworth Research, a Syneos Health company; Claire Riches, Senior Vice President, Global Client Solutions, Syneos Health; and Richard Young, Vice President, Strategy Vault CDMS, Veeva, for the live webinar on Tuesday, November 29, 2022, at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Scaling DCTs to Drive the Transformation of Clinical Development.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Contact:

Vera Kovacevic

Tel: +1 (416) 977-6555 x371

Email: vkovacevic@xtalks.com

Share article on social media or email:

Aceable Report Spotlights Lack of Driver Confidence on the Road


News Image

Today Aceable, the digital driver’s education platform, released a new report revealing that the lack of time Americans have spent driving over the past two years has had significant long-term impacts – namely, higher driving anxiety and road rage.

Aceable’s Parent & Teen Drivers Post-Pandemic Research states that 92% of people drove less over the past two years than before March 2020. And now, even though 73% of people are driving at the same levels as before, 27% of people are still driving less than pre-pandemic. More than half of these (53%) state they feel more anxious about driving now than they did prior to March 2020 with Gen Z drivers (ages 18-25) 22% more likely to say they experience driving anxiety.

What is causing this anxiety? 47% of drivers admit that a lack of drive-time during the pandemic caused their driving abilities to deteriorate. But their anxiety doesn’t stem solely from a lack of trust in their own abilities, but also that of fellow drivers. 58% worry that other drivers’ skills have worsened since the pandemic’s onset, and a third of those on the road do not feel confident in the driving abilities of others behind the wheel.

Drivers also experience anxiety due to varying road conditions such as time of day and destination. Of those experiencing driving anxiety, 42% say that the morning causes more anxiety while driving than any other time of the day and 39% feel anxiety caused by traffic congestion. As more employees make the return to office, work-related stress can impact a commute with 52% of respondents mentioning work stress as a source of driving-related anxiety. Coupled with an extended period of time away from the wheel, an increase in commuters on the road can make for a stressful driving experience.

Driving with anxiety can have potentially dangerous outcomes, especially because anxiety in drivers tends to manifest in harmful habits and reactions like road rage. 68% of drivers expressed they’ve seen an increase in road rage from other drivers compared to pre-pandemic. But nobody is immune: 62% admitted to increased feelings of road rage themselves since getting back on the road in 2022, with men 22% more likely to say this. Anxiety and road rage are significant distractions for those in the driver’s seat. Most of the time, a defensive driving mindset is put on the back burner, increasing the risk of accidents.

“It’s clear drivers want to return to the road after two years of pandemic shutdowns and isolation from friends and family,” said Aceable Senior Driving Analyst Laura Adams. “But it’s alarming to see both an increase in anxiety and road rage in drivers hitting the road today. For many, the reality is that a lack of practice has impacted driving skills. That correlates to the data showing drivers are more anxious and quicker to anger. So, drivers should brush up on driving skills to be safer behind the wheel.”

According to Aceable’s report, defensive driving courses are in high demand post-pandemic, with 64% of respondents indicating they have taken a course since the onset of the pandemic. In order to meet the demand and make courses more accessible as well as convenient, Aceable made history with the launch of a first-of-its-kind audio-only defensive driving course. The course, available now in Texas and with plans to expand, is designed to play like a podcast with audio in the background, allowing consumers to cut out hours of screen time and ingest information in the way that works best for them.

Additional findings from Aceable’s Parent & Teen Drivers Post-Pandemic Research include data correlated to teen driving anxiety as a result of the pandemic. 9 in 10 parents reported their teen postponed getting their license because they were anxious about driving. This is largely due to a lack of driving experience caused by pandemic shutdowns, adding getting a license to the list of ways COVID-19 has impacted how people go about their day to day lives.

About Aceable

Aceable is a digital education platform that exists to provide unparalleled, accredited digital driving training to build the life people want. Named one of the Best Places to Work in Austin for multiple years running by numerous entities, including Austin Business Journal, BuiltInAustin and EqualOcean, Aceable is headquartered in Austin, TX, but our team works remotely across select states in the U.S. For more information, visit http://www.aceable.com

Share article on social media or email:

Healthfully Partners With Tenovi to Offer Simplified Remote Patient Monitoring Devices


News Image

“Healthfully has masterfully created an ecosystem centered around improving patient care. This shared vision of maximizing patient value at every corner is what excites me most about our partnership.” – Dr. Nizan Friedman, CEO, Tenovi

Healthfully®, an enterprise digital healthcare solutions company providing white-label technology platforms, today announced a partnership with Tenovi to offer simplified remote patient monitoring devices as part of their suite of digital health tools. Healthfully clients will now be able to give patients easy-to-use Internet-enabled devices for monitoring vital signs at home as part of their care plan—no smartphone or WiFi needed.

While many digital healthcare solution providers, including Healthfully, offer remote patient monitoring through smartphone apps or smart watches, older patients or those without an Internet connection may not be able to use these tools consistently. Tenovi eliminates the need for any apps, smartphones or even an Internet connection, because its devices are compatible with all cellular carriers globally. Tenovi devices that monitor vital signs such as blood oxygen levels, blood pressure, blood glucose and weight do not require any special setup or syncing, and automatically transmit data to a patient’s provider.

“We believe that remote patient monitoring devices that are connected via the Internet of Things (IoT) are the future,” said Paul Viskovich, CEO of Healthfully. “Better remote patient monitoring post-discharge leads to lower readmittance in hospitals, and ongoing remote patient monitoring improves health outcomes. But not everyone has equal access to the Internet or smartphones, and not every patient is able to navigate this technology easily. Simplifying the user experience encourages adoption and ongoing use of remote patient monitoring. This is why we are very excited to be working with Tenovi, in order to offer our enterprise clients a complete set of simple, cost-effective monitoring devices.”

Patients who use Tenovi’s IoT devices report far less time spent setting up the device at home, and greater ease of use. This in turn leads to more patient data that their providers can use to improve their care. In fact, an internal study found that Tenovi’s platform increased the number of patients eligible for MediCare CPT 99454 reimbursement by 27% when compared to other leading cellular remote patient monitoring devices.

Integrating Tenovi devices with Healthfully’s white-label digital healthcare technology platform will enable healthcare providers to improve patient adherence and outcomes, and allow them to reach more patients regardless of age, income or technology knowledge. The partnership with Tenovi is just the latest step in Healthfully’s mission to help patients get the care they need, the support they want and the inspiration to achieve better health.

“Healthfully has masterfully created an ecosystem centered around improving patient care,” said Dr. Nizan Friedman, CEO of Tenovi. “This shared vision of maximizing patient value at every corner is what excites me most about our partnership. Together, we aim to lower the barriers to remote patient monitoring for healthcare-focused organizations of every size.”

The Healthfully-Tenovi partnership will also be announced in a presentation at the 2022 HLTH Conference, taking place November 13-16 in Las Vegas. Tenovi devices will be available to test at Healthfully’s booth on the expo floor.

About Healthfully

Healthfully unifies access, support, and rewards to optimize consumer health. We provide enterprise organizations with a white-label, digital health experience platform to engage and empower consumers on their health and wellness journey. The platform blends compelling and valuable functions, intelligence, and content for patients, consumers, and communities, creating a great patient experience and helping achieve the goals of value-based care and population health management. http://www.healthfully.io

About Tenovi

Tenovi is an automation platform that serves as the conduit between medical device manufacturers and remote patient monitoring (RPM) companies. Their cellular gateway seamlessly automates data transfer of a growing number of FDA approved devices to care management platforms; their API-driven fulfillment and kitting service automates device and supplies delivery; and their client engagement platform automates ticketing support, billing, and device management.

Media Contact:

Sarah Flocken

sarah@conwaymarketinggroup.com

###

Share article on social media or email:

Applied Radiology Announces the Winners of the 2022 “Leaders on the Horizon” Residents’ Program


“Applied Radiology is committed to supporting the field of radiology and is delighted to work with today’s radiology residents, who are the future of imaging,” said Kieran Anderson, vice president and group publisher of Anderson Publishing.

Anderson Publishing, Ltd., publishers of Applied Radiology, a leading clinical-review publication and website for radiologists and affiliated professionals, is pleased to announce the winning authors in the 2022 “Leaders on the Horizon” Residents’ Program, which challenged radiology residents to submit research papers on topics related to MRI for consideration. The following five residents from around the country are this year’s winners.

1. Jordan Chamberlin, MD, Medical University of South Carolina

2. Alexander Satei, MD, Trinity Health Oakland – Wayne State University

3. Melina Hosseiny, MD, University of California San Diego

4. Moozhan Nikpanah, MD, University of Alabama at Birmingham

5. Akarshan Monga, MD, Detroit Medical Center

In addition to their scholarship awards, the winning papers will be published in a special supplement to Applied Radiology appearing in early 2023. The authors of the top two papers will also be invited to attend the 2022 Radiological Society of North America Scientific Meeting and Exhibition, where they will be honored at a special reception to be held at the Marriott Marquis on November 27, 2022.

This year’s winners were chosen by a review board comprised of ten expert radiologists and educators covering various sub-specialties in radiology, and both Applied Radiology and Bracco Diagnostics would like to thank them all for the time and effort they put into this program.

Sponsored by Bracco Diagnostics, Inc., the “Leaders on the Horizon” Residents’ Program champions the next generation of radiology leaders. The program offers residents the opportunity to be recognized for their outstanding clinical research while expanding their knowledge of the imaging industry. This program is a key component of Applied Radiology and Bracco Diagnostics’ ongoing commitment to advancing medical imaging knowledge, leadership, and education.

“Applied Radiology is committed to supporting the field of radiology and is delighted to work with today’s radiology residents, who are the future of imaging,” said Kieran Anderson, vice president and group publisher of Anderson Publishing. “Programs like “Leaders on the Horizon” provide an opportunity for young residents to explore new areas of imaging, potentially having a profound effect on their career and the field as a whole. We salute these residents and are delighted to be a part of their journey.

For more information about the “Leaders on the Horizon” Residents’ Program, visit: appliedradiology.com/leaders

About Applied Radiology

Applied Radiology is a physician-authored, clinical review journal that has been published for over 50 years and reaches radiologists and related imaging professionals in print and digital formats. Its comprehensive content includes practical review articles, radiological cases, technology and industry updates, editorials, and related columns. Applied Radiology is published by Anderson Publishing, Ltd., a multimedia company dedicated to the development of high-quality, clinically relevant content designed to meet the needs of today’s medical professionals. Learn more at http://www.appliedradiology.com

About Bracco Imaging

Bracco Imaging S.p.A., part of the Bracco Group, is a world-leading diagnostic imaging provider. Headquartered in Milan, Italy, Bracco Imaging develops, manufactures and markets diagnostic imaging agents and solutions. It offers a product and solution portfolio for all key diagnostic imaging modalities: X-ray imaging (including Computed Tomography-CT, Interventional Radiology, and Cardiac Catheterization), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound (CEUS), and Nuclear Medicine through radioactive tracers and novel PET imaging agents to inform clinical management and guide care for cancer patients in areas of unmet medical need. Our continually evolving portfolio is completed by a range of medical devices, advanced administration systems and dose-management software. In 2019 Bracco Imaging enriched its product portfolio by expanding the range of oncology nuclear imaging solutions in the urology segment and other specialties with the acquisition of Blue Earth Diagnostics. In 2021, Bracco Imaging established Blue Earth Therapeutics as a separate, cutting-edge biotechnology dedicated to advancing next generation targeted radiotherapeutics to treat patients who have cancer. Visit: http://www.braccoimaging.com.

Contact

Anderson Publishing, Ltd.

Kieran Anderson

Vice President

kieran@appliedradiology.com

D: +1 908-337-3366

Bracco Diagnostics Inc. Media Relations (USA)

Kimberly Gerweck

Senior Manager, Marketing Communications

BDIMediaContact@diag.bracco.com

D: +1 609-524-2777

Share article on social media or email:

Platinum Member Codoxo to Present at 2022 NHCAA Institute for Health Care Fraud Prevention’s Annual Training Conference


Codoxo Presents At NHCAA

“We hope that by sharing this case study, NHCAA attendees will glean insight into best practices that they can incorporate into their own fraud prevention programs and see first-hand how AI is helping health plans take their FWA programs to the next level.”

Codoxo, a trusted provider of healthcare artificial intelligence solutions for healthcare payers and agencies, today announced it will present live at the NHCAA Institute for Health Care Fraud Prevention’s Annual Training Conference on Thursday, November 17 at 10:00 a.m. Eastern Time at the Hyatt Regency in Orlando, Florida. Platinum Member, Codoxo, is thrilled to support the industry’s leading healthcare anti-fraud events, as it serves to share information on best practices to detect, investigate, prosecute, and prevent fraud, waste, and abuse (FWA).

Derik Ciccarelli, Healthcare Fraud Analyst with Codoxo, will co-present “Coordination Is King: Use Case of Impossible Days” alongside Sandra Caffarella, RN, CPC, CPMA, AHFI, Leader of Investigations, Special Investigations Unit, MVP Health Care. The speakers will demonstrate how Codoxo’s artificial intelligence (AI)I-based fraud detection platform enabled MVP Health Care analysts to quickly identify a suspicious provider that was billing impossible days by exposing a significant spike in the baseline of claims per month, primarily for their Medicaid population. MVP Health Care and Codoxo will share best practices, including the steps that MVP Health Care’s SIU team took to quickly move into action, procure recovery, and achieve cost avoidance.

“Codoxo works closely with its healthcare payer, agency, and PBM clients to provide cutting-edge AI solutions that detect and minimize risks from fraud, waste, and abuse,” stated Dr. Musheer Ahmed, Codoxo’s Chief Executive Officer and founder. “We hope that by sharing this case study, NHCAA attendees will glean insight into best practices that they can incorporate into their own fraud prevention programs and see first-hand how AI is helping health plans take their FWA programs to the next level.”

Codoxo will showcase its Unified Cost Containment Platform in Booth 115, and will be demonstrating how the platform is helping healthcare payers and agencies maximize savings and lower provider abrasion through a unified cost containment approach. Codoxo will also be participating in the Bingo event and holding its own booth giveaway drawing for a reMarkable tablet.

Codoxo is a member of NHCAA and has a stated mission “to make healthcare more affordable and effective for everyone.” Through its proprietary Forensic AI Engine and Unified Cost Containment Platform, it is disrupting the cost containment and payment integrity industry by implementing the most innovative and effective AI available to reduce fraud, waste, and abuse and ensure payment integrity for health payers, agencies and PBMs.

To find out more about Codoxo and its transformation AI capabilities, please visit https://www.codoxo.com.

About Codoxo

Codoxo’s mission is to make healthcare more affordable and effective for everyone and serves

as the premier provider of artificial intelligence-driven solutions and services that help healthcare companies and agencies proactively detect and reduce risks from fraud, waste, and abuse. The Codoxo Unified Cost Containment Platform helps clients manage costs across network management, clinical care, provider coding and billing, program integrity, and special investigation units. Our software-as-a-service applications are built on our proven Forensic AI Engine, which uses patented AI-based technology to identify problems and suspicious behavior far faster and earlier than traditional techniques. Our solutions are HIPAA-compliant and operate in a HITRUST-certified environment. For additional information, visit http://www.codoxo.com.

Share article on social media or email:

Kno2 and Axxess Join Together To Transform Home Health Care Delivery Across the United States Through Information Sharing


News Image

“Kno2’s API provides us the most comprehensive yet cost-effective way to embed information-sharing practices into existing workflows, which is the key to driving adoption and usage for our clients.”

Kno2®, the company leading the future of healthcare communications, and Axxess, the leading technology innovator for healthcare at home, today announced a new joint software integration that will enable healthcare providers easy access to secure patient information, ensuring effective transitions of care. Axxess will leverage Kno2’s Communication API to connect and equip its home health, home care, hospice, and palliative care clients with technology for interoperable health data sharing.

Studies have long showed Americans prefer care at home. A recent report by McKinsey & Company found that in the aftermath of the coronavirus pandemic there is an estimated $265 billion of care services that could shift from hospitals and other traditional care facilities to the home by 2025. The ability to effectively communicate and share critical patient information with all members of the care team, regardless of setting, is foundational for organizational success.

“Moving more care to the home is critical if we want to address some of the most difficult challenges facing our healthcare system, including caring for our country’s aging population,” said Therasa Bell, co-founder, president, and chief technology officer at Kno2. “Axxess’ passion for the home market and providers serving in the home is shared with Kno2’s passion to bring information sharing and communication to all aspects of care. Together, we will disrupt and improve the way healthcare is delivered.”

“We selected an integration partner whose technology will significantly benefit our clients by extending our capabilities to the broader healthcare ecosystem,” said Tim Ingram, executive vice president of interoperability at Axxess. “Kno2’s API provides us the most comprehensive yet cost-effective way to embed information-sharing practices into existing workflows, which is the key to driving adoption and usage for our clients.”

By seamlessly integrating Kno2’s Communication API across its suite of post-acute electronic health record (EHR) systems and workflows, Axxess users will effortlessly exchange clinical data for the patient.

Kno2 is a proud sponsor of the first-ever Axxess Growth, Innovation and Leadership Experience, known as AGILE, which will be held April 17-19, 2023, in Dallas, Texas. The conference will aim to help the care at home industry anticipate and share solutions that solve challenges, ensure high-quality patient care and help organizations grow. Visit axxess.com/agile to register online and view more details.

###

About Kno2

The Kno2 network enables the secure, effortless and maximized exchange of patient information across patients, providers, payers and IT vendors. We are empowering healthcare to finally realize the true potential of interoperability by unleashing connectivity everywhere through a simple to use Communication API and robust tools for any business. With industry disrupting economics and our passion to include the underserved, Kno2 is democratizing healthcare communications and defining the new connected future of healthcare. With a single connection to Kno2, anyone can quickly gain access to a powerful network of connected networks, EHRs, HIEs, organizations, technologies and interoperability frameworks that gives the freedom to easily communicate with all. To learn more, visit http://www.kno2.com

About Axxess

Axxess is the leading technology innovator for healthcare at home, focused on solving the most complex industry challenges. Trusted by more than 9,000 organizations that serve more than 3 million patients worldwide, Axxess offers a complete suite of easy-touse software solutions that empower home health, home care, hospice, and palliative providers to make healthcare in the home human again. The company’s collaborative culture focused on innovation and excellence is recognized nationally as a “Best Place to Work.”

Share article on social media or email:

Groundbreaking Memory Supplement Vitaae® with New Citicoline Sodium to Address Brain Fog, Memory Issues, and Other Troubling Signs of Cognitive Decline After Middle Age A


This is one of the most important medical discoveries in the 21st Century, as it gives us the time and opportunity to address the likely causes of cognitive decline, like neurological inflammation, before it advances to more severe brain issues, which is why we created SANE Vitaae®. (1)

Today, SANESolution is announcing a groundbreaking supplement called SANE Vitaae® to naturally support healthy brain function and address brain fog and other cognitive issues so common in those 40 and older, now available on Amazon. With memory glitches and brain fog an increasingly common issue in middle age, Vitaae® is a new tool to respond to the neurological inflammation shown to be a significant risk factor for cognitive dysfunction.

“Age-related memory loss is widely believed to begin around 60,” said Matthew Olesiak, M.D., the Chief Medical Director at SANESolution. “While it’s true that brain problems are more common in people over the age of 65, new research suggests that memory loss, brain fog, and other signs of cognitive decline may begin decades earlier. This is one of the most important medical discoveries in the 21st Century, as it gives us the time and opportunity to address the likely causes of cognitive decline, like neurological inflammation, before it advances to more severe brain issues, which is why we created SANE Vitaae®.” (1)

When researchers examined data from an ongoing British health study called Whitehall II, they made a shocking discovery. Over a decade, approximately 5,200 men in the study and 2,200 women between the ages of 45 and 70 were tested on three separate occasions to assess memory, mental reasoning, and language. The testing showed a cognitive decline at all age levels. Over the 10-year evaluation, participants in their mid-to-late 40s when testing began experienced a 3.6% decline in mental reasoning, compared to a 9.6% decline among those in their mid-to-late 60s. (2)

Dr. Olesiak said, “these findings do not suggest that people in their 40s are walking around with severe brain issues. Fortunately, the cognitive decline shown in this evaluation was minimal. But it does indicate a potential ‘brain health storm’ as millions of these individuals approach their 60s. Science has shown us there is something we can do to naturally relieve brain inflammation, along with the resulting cognitive dysfunction plaguing many people today. Vitaae® combines the most potent and effective grade brain-health nutrients that have been shown to help support the body’s natural recovery systems maximally.”

Developed by a team of researchers led by Dr. Olesiak and Jonathan Bailor, Founder, and CEO of SANESolution, the SANE Vitaae® memory supplement contains a proprietary blend of ingredients that research suggests may help naturally soothe brain inflammation while supporting healthy brain function.

Vitaae® contains Citicoline sodium, a new form of citicoline that has been shown to boost brain energy and improve memory, attention, focus, and motor speed in clinical trials. Citicoline has demonstrated its ability to increase phosphatidylcholine, an essential component of cell membranes needed for proper brain function. (7, 8, 9)

Citicoline was first developed and used as a drug in 1970s Japan to treat stroke patients and was found to significantly increase the chances of making a complete recovery if administered within the first 24 hours of having the stroke. A naturally occurring body chemical with proven neuroprotective effects, citicoline has been used effectively to treat the cognitive symptoms of neurodegenerative diseases characterized by neuroinflammation. Today, citicoline is available as a medication and brain health supplement in Europe and the United States. (10)

During his research, Dr. Olesiak also identified several other nutrients that support brain health and function while defending against neurological inflammation, including folate, acetyl-l-carnitine, and coenzyme Q-10 (CoQ10), which he also included in the supplement to provide people with a comprehensive multi-factor formula for brain health.

Now available for purchase nationwide, Vitaae® is the breakthrough health product of 2022 as it may address brain inflammation, potentially supporting the body’s natural ability to recover from unpleasant and sometimes crippling brain fog, memory lapses, poor concentration, and other signs of poor brain function.

For more information or to purchase Vitaae® on Amazon, visit: https://www.amazon.com/Vitaae-Cognizin-Citicoline-Memory-Supplement/dp/B08GQDW8V8/

###

About SANESolution:

SANESolution is a wellness technology and metabolic healing company dedicated to ending the Diabesity (diabetes plus obesity) epidemic. Backed by 1,300 clinical studies and thousands of success stories, SANESolution’s metabolic healing framework and model is the only program endorsed by top doctors at the Harvard Medical School, Johns Hopkins, the Mayo Clinic, the Cleveland Clinic, and UCLA, and is the subject of New York Times best-selling books, and award-winning documentaries. Started as a not-for-profit research project by a ten-year Microsoft alum, Jonathan Bailor, SANESolution has transformed into a trusted international wellness brand focused on reversing the most common and devastating modern diseases. Using the latest innovations in biochemical research and a “service-first story-based” marketing approach to reach, lift up, and educate consumer health choices, SANESolution is changing the world of wellness by helping everyone from the underprivileged to the Fortune 500 CEO to regain their “SANEity” one new “SANE” consumer at a time. SANESolution was inducted into Inc. 5000’s list of “Fastest-Growing Private Companies in America” for 2020. For more information, visit: https://store.sanesolution.com

SANE Vitaae™ Ingredients:

Vitamin D (as cholecalciferol)

Folate (as 5-MTHF from Calcium Methyltetrahydrofolate)

Acetyl L-carnitine HCL

L-Carnitine Tartrate

Gymnema sylvestre Leaf Extract 25% Gymnemic Acid

Omega-3 Fish Oil Miroencapsulated (9% EPA, 6% DHA)

Citicoline Sodium (CDP-Choline)

CoQ10 (as HydroQsorb®)

Other ingredients: Gelatin, magnesium stearate, silica, and rice flour.

Scientific References

1- https://www.webmd.com/brain/news/20120105/memory-loss-may-occur-40s

2- https://onlinelibrary.wiley.com/doi/full/10.1002/acn3.51578

3- https://www.cdc.gov/aging/pdf/cognitive_impairment/cogimp_poilicy_final.pdf#:~:text=More%20than%2016%20million%20people%20in%20the%20United,people%20living%20with%20cognitive%20impairment%20in%20your%20state.

4- https://medicalxpress.com/news/2022-03-memory-problems-common-covid-scientists.html

5- https://pubs.rsna.org/doi/10.1148/radiol.2020201697

6- https://pubmed.ncbi.nlm.nih.gov/33796241/

7 – https://www.nih.gov/news-events/news-releases/researchers-highlight-covid-19-neurological-symptoms-need-rigorous-studies

8- https://journals.sagepub.com/doi/10.1177/1087054715593633

9 – https://cognizin.com/en/studies/chronic-citicoline-increases-phosphodiesters-in-the-brains-of-healthy-older-subjects-an-in-vivo-phosphorus-magnetic-resonance-spectroscopy-study

10 – https://cognizin.com/en/studies/chronic-citicoline-increases-phosphodiesters-in-the-brains-of-healthy-older-subjects-an-in-vivo-phosphorus-magnetic-resonance-spectroscopy-study

Share article on social media or email:

Huma Mirza, D.D.S. of Smile! Dental Boutique Awarded NJ Top Dentist For 2022


Dr. Huma Mirza

Dr. Huma Mirza

Huma Mirza, DDS of Smile! Dental Boutique in Warren, New Jersey has been reviewed and approved by NJ Top Dentists for 2022. Dr. Mirza’s key mission as a dentist is to provide her patients with a new, positive outlook on dentistry.

Dr. Mirza provides a full spectrum of general dentistry and cosmetic dentistry services at her Warren, New Jersey office. She has expertise with porcelain veneers, dental implants, crowns, and bridges.

Dr. Mirza graduated from United Medical and Dental School of Guys’, Kings and St Thomas’ in London in 2002 – one of the most prestigious dental schools in the United Kingdom. She graduated at the top of her class, winning prizes in orthodontics, pediatric dentistry, dental public health, microbiology, immunology, pathology, conservative dentistry, and was entered to win the Gold Medal prize for best dental student in London, in which she achieved the runner up position.

Upon graduating she married and moved to America where she attended NYU College of Dentistry graduating in 2006 with the highest GPA in her class. She was on the Dean’s list for all 3 years at NYU and won the Ethics prize and a certificate of achievement in recognition of outstanding achievements.

Dr. Mirza then took part in the honors program in Oral Surgery, and was inducted into the omega chapter of OKU, an elite dental society joined by invitation only. Upon graduating from dental school Dr. Huma has taken extensive continuing education classes to improve her skill range, enabling her to be able to provide an extensive range of treatments for her patients, and helping her keep abreast of new technologies available.

Whether you need a simple filling or a full cosmetic reconstruction, Dr. Mirza has the knowledge, expertise and equipment to meet your needs with the best treatment the industry has to offer.

To learn more about Dr. Huma Mirza and her practice, Smile! Dental Boutique please visit: https://njtopdocs.com/nj-dentists/drhumamirza/

—-

About Us

NJ Top Dentists is a division of NJ Top Docs. NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email: